Simple view
Full metadata view
Authors
Statistics
Quantification and pharmacokinetics of 1-methylpyridinium and 1,4-dimethylpyridinium in rats by liquid chromatography tandem mass spectrometry : tissue distribution of 1,4-dimethylpyridinium in rats
LC/MS/MS
method validation
derivatives of pyridinium compounds
pharmacokinetics
A sensitive and specific liquid chromatography tandem mass spectrometry method for quantification of 1-methylpyridinium (1-MP) and 1,4-dimethylpyridinium (1,4-DMP) in rat plasma and tissues homogenates was developed. Chromatographic separation was performed on an Aquasil C18 analytical column with an isocratic elution of acetonitrile and water, both with an addition of formic acid (0.1%, v/v). Detection was achieved by triple quadrupole mass spectrometer TSQ Quantum Ultra equipped with a heated electrospray ionization source (HESI). The limit of quantification for both compounds was 0.05 μg/mL in plasma and 0.25 μg/g in studied tissues. The method was applied to pharmacokinetics and bioavailability of both 1-MP and 1,4-DMP with tissue distribution of 1,4-DMP in rats. Pharmacokinetic studies of 1-MP and 1,4-DMP were carried out following their intravenous or intragastric administration to male Wistar rats at the dose of 100 mg/kg. The terminal half-lives of 1-MP and 1,4-DMP after their intravenous administration were 55.3 and 70.8 min, respectively. The absolute bioavailability was 51 and 31% for 1-MP and 1,4-DMP, respectively.
dc.abstract.en | A sensitive and specific liquid chromatography tandem mass spectrometry method for quantification of 1-methylpyridinium (1-MP) and 1,4-dimethylpyridinium (1,4-DMP) in rat plasma and tissues homogenates was developed. Chromatographic separation was performed on an Aquasil C18 analytical column with an isocratic elution of acetonitrile and water, both with an addition of formic acid (0.1%, v/v). Detection was achieved by triple quadrupole mass spectrometer TSQ Quantum Ultra equipped with a heated electrospray ionization source (HESI). The limit of quantification for both compounds was 0.05 μg/mL in plasma and 0.25 μg/g in studied tissues. The method was applied to pharmacokinetics and bioavailability of both 1-MP and 1,4-DMP with tissue distribution of 1,4-DMP in rats. Pharmacokinetic studies of 1-MP and 1,4-DMP were carried out following their intravenous or intragastric administration to male Wistar rats at the dose of 100 mg/kg. The terminal half-lives of 1-MP and 1,4-DMP after their intravenous administration were 55.3 and 70.8 min, respectively. The absolute bioavailability was 51 and 31% for 1-MP and 1,4-DMP, respectively. | pl |
dc.affiliation | Pion Prorektora ds. badań naukowych i funduszy strukturalnych : Jagiellońskie Centrum Rozwoju Leków | pl |
dc.affiliation | Wydział Farmaceutyczny : Zakład Farmakokinetyki i Farmacji Fizycznej | pl |
dc.affiliation | Wydział Farmaceutyczny : Zakład Toksykologii | pl |
dc.cm.id | 79589 | |
dc.contributor.author | Zakrzewska, Agnieszka - 198214 | pl |
dc.contributor.author | Szafarz, Małgorzata - 133549 | pl |
dc.contributor.author | Kuś, Kamil - 140457 | pl |
dc.contributor.author | Kij, Agnieszka - 215016 | pl |
dc.contributor.author | Gonciarz-Dytman, Anna - 140525 | pl |
dc.contributor.author | Walczak, Maria - 133728 | pl |
dc.date.accession | 2018-12-05 | pl |
dc.date.accessioned | 2018-12-05T07:44:31Z | |
dc.date.available | 2018-12-05T07:44:31Z | |
dc.date.issued | 2016 | pl |
dc.date.openaccess | 0 | |
dc.description.accesstime | w momencie opublikowania | |
dc.description.additional | Bibliogr. s. 1121 | pl |
dc.description.number | 5 | pl |
dc.description.physical | 1111-1121 | pl |
dc.description.points | 15 | pl |
dc.description.version | ostateczna wersja wydawcy | |
dc.description.volume | 73 | pl |
dc.identifier.eissn | 2353-5288 | pl |
dc.identifier.issn | 0001-6837 | pl |
dc.identifier.project | ROD UJ / OP | pl |
dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/62606 | |
dc.identifier.weblink | http://ptfarm.pl/pub/File/Acta_Poloniae/2016/5/1111.pdf | pl |
dc.language | eng | pl |
dc.language.container | eng | pl |
dc.rights | Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa | * |
dc.rights.licence | CC-BY-NC | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/legalcode.pl | * |
dc.share.type | otwarte czasopismo | |
dc.subject.en | LC/MS/MS | pl |
dc.subject.en | method validation | pl |
dc.subject.en | derivatives of pyridinium compounds | pl |
dc.subject.en | pharmacokinetics | pl |
dc.subtype | Article | pl |
dc.title | Quantification and pharmacokinetics of 1-methylpyridinium and 1,4-dimethylpyridinium in rats by liquid chromatography tandem mass spectrometry : tissue distribution of 1,4-dimethylpyridinium in rats | pl |
dc.title.journal | Acta Poloniae Pharmaceutica. Drug Research | pl |
dc.type | JournalArticle | pl |
dspace.entity.type | Publication |
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Views
0
Views per month
Open Access